Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Jonasch

Showing results (51-60 of 271) with videos related to

Pageof 28
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 7, 2022
Current Systemic Treatments for the Hereditary Cancer Syndromes: Drug Development in Light of Genomic DefectsElshad Hasanov, Isabel Pimentel, Mara Cruellas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Durable remission of metastatic renal cell carcinoma with gemcitabine and capecitabine after failure of targeted therapyStephen L Richey, Chaan Ng, Zita D Lim, et al.
Cancer|April 7, 2006
Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanesAlan Rodney, Pauline Dieringer, Paul Mathew, et al.
Clinical Genitourinary Cancer|January 22, 2023
Epidemiology and Economic Burden of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma in the United StatesEric Jonasch, Yan Song, Jonathan Freimark, et al.
Clinical Genitourinary Cancer|February 14, 2009
Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenibZita Dubauskas, Joy Kunishige, Victor G Prieto, et al.
Orphanet Journal of Rare Diseases|February 16, 2024
Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United StatesEric Jonasch, Yan Song, Jonathan Freimark, et al.
European Urology|February 18, 2005
Port-site metastasis: the influence of biologyRalph A Highshaw, Funda Vakar-Lopez, Eric Jonasch, et al.
Cancer|April 30, 2009
Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinomaAmado J Zurita, Eric Jonasch, Hua-Kang Wu, et al.
Medicine|August 24, 2017
Effects of tamoxifen on urinary incontinence: Case report and review of literatureElshad Hasanov, Merve Hasanov, Issa M Kuria, et al.
Journal of Behavioral Medicine|June 18, 2014
Psychological states, serum markers and survival: associations and predictors of survival in patients with renal cell carcinomaSarah Prinsloo, Qi Wei, Shellie M Scott, et al.
Pageof 28

Showing results (51-60 of 271) with videos related to

Sort By:
Pageof 28
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 7, 2022
Current Systemic Treatments for the Hereditary Cancer Syndromes: Drug Development in Light of Genomic DefectsElshad Hasanov, Isabel Pimentel, Mara Cruellas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Durable remission of metastatic renal cell carcinoma with gemcitabine and capecitabine after failure of targeted therapyStephen L Richey, Chaan Ng, Zita D Lim, et al.
Cancer|April 7, 2006
Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanesAlan Rodney, Pauline Dieringer, Paul Mathew, et al.
Clinical Genitourinary Cancer|January 22, 2023
Epidemiology and Economic Burden of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma in the United StatesEric Jonasch, Yan Song, Jonathan Freimark, et al.
Clinical Genitourinary Cancer|February 14, 2009
Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenibZita Dubauskas, Joy Kunishige, Victor G Prieto, et al.
Orphanet Journal of Rare Diseases|February 16, 2024
Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United StatesEric Jonasch, Yan Song, Jonathan Freimark, et al.
European Urology|February 18, 2005
Port-site metastasis: the influence of biologyRalph A Highshaw, Funda Vakar-Lopez, Eric Jonasch, et al.
Cancer|April 30, 2009
Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinomaAmado J Zurita, Eric Jonasch, Hua-Kang Wu, et al.
Medicine|August 24, 2017
Effects of tamoxifen on urinary incontinence: Case report and review of literatureElshad Hasanov, Merve Hasanov, Issa M Kuria, et al.
Journal of Behavioral Medicine|June 18, 2014
Psychological states, serum markers and survival: associations and predictors of survival in patients with renal cell carcinomaSarah Prinsloo, Qi Wei, Shellie M Scott, et al.
Pageof 28